Nova Health
NOVA HEALTHHome nursing and physiotherapy
Occupational therapy for Parkinson's disease

Sudden Addiction to Gambling, Loss of Control Over Shopping and a Raised Sex Drive Are Mostly Parkinson's Medicine Side Effects, and Do Not Mean the Person's Character Has Broken Down

An older man who has been thrifty and honest for most of his life suddenly, after starting Parkinson's medicine, shops online compulsively, gambles in secret, and even has a sexual drive so much higher that his spouse complains of being troubled. The first reaction of many families is often: "Has he become a different person?" Some suspect that the older adult has "gone bad in old age". This article aims to clarify one important fact: such unusual behaviour is very likely not a breakdown of character, but a drug side effect supported by large studies, which medicine calls an "impulse control disorder" (ICD).

This is a sensitive subject that can easily break up a family, yet public education about it in Hong Kong is almost a blank. The sections below therefore explain in detail the cause of this side effect, the high-risk groups and how families can recognise it, and stress three most important principles: do not scold, tell the doctor as soon as possible, and do not stop the medicine alone.

First, the position of this page. This article gives educational information for carers from the occupational therapy point of view, and gives no guidance on changing medicines. Any adjustment of medicine (for example reducing the dose of a dopamine receptor agonist) should always be handled by a neurologist or the treating doctor. The local statistics quoted (such as the number of patients in Hong Kong and remarks by local experts) are estimates from local media reports and are not strict academic data. The sources are listed at the end of the article.

The most important point is that the patient has not turned bad, and is affected by a drug side effect. If a family member with Parkinson's disease suddenly becomes addicted to gambling, loses control over shopping, has a much higher sex drive or binge eats, never scold the person's character or morals, because this only hurts the relationship and makes the person hide more deliberately. The right approach is to stay calm, not scold, help to record the unusual behaviour, and tell the prescribing doctor as soon as possible so that the doctor can adjust the medicine. Never increase or reduce the dose or stop the medicine alone.

What is an impulse control disorder, and its four common forms

An impulse control disorder (ICD) means that the patient loses self-control over a certain type of behaviour and cannot stop, even when knowing it will have bad consequences. In people with Parkinson's disease, the four most common forms are as follows:

Pathological gamblingThe patient becomes addicted to gambling, betting on football or gambling apps on the phone, and cannot stop even while losing money, and may borrow money or buy on credit to gamble. The DOMINION study showed that the prevalence of this is about 5.0%.
Compulsive buyingThe patient shops online or buys things everywhere without control, buying a lot of things that are not needed, so the home is suddenly piled with parcels. The prevalence of this is about 5.7%.
HypersexualityThe patient's sexual drive rises clearly, and the person often browses pornographic content, with clear changes in speech or behaviour that sometimes cause the partner great distress. The prevalence of this is about 3.5%.
Binge eatingThe patient eats and drinks without control, and body weight rises sharply in a short time. The prevalence of this is about 4.3%.

(The four prevalence figures above are all taken from the DOMINION study published by Weintraub et al. in 2010.) Besides these four main forms, some patients also show repetitive and aimless stubborn behaviours, such as taking apart and putting together objects or tidying things non-stop (called punding in medicine), which also belong to the spectrum of this condition (Weintraub et al., 2009).

How Parkinson's medicines cause impulse control disorders

To understand the cause, it is necessary to start from how Parkinson's disease is treated. Parkinson's disease comes from the degeneration of nerve cells in the brain that produce dopamine, so medicines that replace dopamine are commonly used in treatment, including a group called "dopamine receptor agonists" (such as pramipexole and ropinirole). The problem is that, besides improving motor symptoms, these medicines also stimulate the nerve circuits in the brain that deal with "reward and pleasure".

The agonist over-stimulates the D3 receptors linked to the reward circuit, so the patient loses the brakes on gambling, buying, sex and eating. This is brain chemistry driven by medicine, and it is not the patient's own choice.
The core mechanism of impulse control disorders

In terms of pharmacology, pramipexole and ropinirole have an especially high affinity for the D3 receptors in the brain (about 100 times and 25 times that for D2 receptors respectively), and D3 receptors are densely distributed in the mesolimbic system, which governs reward and motivation. When this circuit is over-stimulated, the patient loses the ability to inhibit behaviours that bring pleasure, such as gambling, shopping, sexual behaviour and eating (Zhang et al., 2021). This is therefore purely a physiological reaction of the brain driven by medicine, and has nothing to do with personality.

How common impulse control disorders are, and the research data

Many families think that "such an out-of-control and outrageous behaviour must be very rare". The research data show, however, that ICD is quite common among people with Parkinson's disease who take dopamine agonists:

13.6%
The overall proportion with an impulse control disorder among 3,090 treated patients with Parkinson's disease at 46 movement disorder centres in the United States and Canada
Weintraub et al., 2010, Arch Neurol (DOMINION cross-sectional study)
17.1% vs 6.9%
The gap in the proportion with ICD between patients taking a dopamine receptor agonist and patients not taking it (about 2.7 times the risk)
Weintraub et al., 2010, Arch Neurol
About 46%
Cumulative incidence of ICD in a five-year follow-up of early Parkinson's disease (as high as 51.5% in patients taking an agonist and only 12.4% in those who never used one), and the higher the dose and the longer the treatment, the higher the risk
Corvol et al., 2018, Neurology (prospective follow-up)

It should be noted that DOMINION is a cross-sectional study (it counts the proportion affected at a single point in time), while the study published by Corvol et al. in 2018 is a prospective follow-up(it counts the proportion of people who develop symptoms cumulatively over several years), so the two sets of data cannot be compared directly. Both studies nevertheless confirm a fact: the longer the treatment and the higher the dose, the greater the risk of the side effect. Another authoritative review also pointed out that about 17% of people with Parkinson's disease taking dopamine receptor agonists develop an impulse control disorder (Voon et al., 2017).

High-risk medicines and patient groups at higher risk

Taking Parkinson's medicine does not necessarily cause the side effect above, but the following factors raise the risk markedly. If the family can recognise these high-risk factors, they can become alert early:

High-risk factors

  • Patients taking dopamine receptor agonists (for example pramipexole and ropinirole), which is the main risk factor.
  • Patients on a higher dose or taking the medicine for longer, because the risk rises with dose and duration of treatment.
  • Patients with a younger age of onset, because younger patients more often start with an agonist early in treatment.
  • Male patients, among whom increased sex drive and pathological gambling are more common.

Clinical reasons why doctors prescribe dopamine agonists

  • With the traditional medicine levodopa, after long-term use (about 5–7 years) patients more easily develop fluctuations in medicine effect such as dyskinesia.
  • For younger patients, doctors therefore sometimes prescribe a dopamine agonist first, hoping to delay the start of levodopa.
  • In other words, there are clinical reasons for prescribing an agonist, and the wrong medicine has not been prescribed.
  • The point is that if the patient develops ICD symptoms, the doctor should be told early so that the benefits and risks can be weighed again and the medicine adjusted.

(For a review of the related risk factors, see Zhang et al., 2021. For the dependence on dose and time, see Corvol et al., 2018. The part on how doctors choose medicines is taken from a media interview with a local neurology expert and is an estimate from a local report.)

Department of Health information and analysis by local experts in Hong Kong

In Hong Kong, public education about this drug side effect is almost a blank, but there are two highly authoritative official and medical sources locally that have long stated it clearly:

Drug Office, Department of Health, Hong KongThe government's official consumer information page on "oral anti-Parkinson's medicines" clearly lists "compulsive behaviours such as increased sex drive, gambling and binge eating" as side effects of dopamine agonists (including pramipexole, ropinirole and bromocriptine), and also mentions the risk of sudden falling asleep. This is the local government's official statement in Chinese (a local official source).
Neurology expert at the Faculty of Medicine, The Chinese University of Hong KongMing Pao Health (明報健康網) quoted the analysis of Dr 陳然欣 of the neurology division at the Faculty of Medicine of The Chinese University of Hong Kong, who said that about 17% of patients develop compulsive side effects such as excessive shopping, overeating and gambling after taking dopamine receptor agonists. The report also shares real clinical cases (an estimate from a local report).
Number of patients locallyThere are estimated to be about 12,000 people with Parkinson's disease in Hong Kong (Ming Pao, quoting data from The Chinese University of Hong Kong. This is an estimate from a local report and not a prevalence from academic research).
About 12,000
Estimated number of people with Parkinson's disease in Hong Kong (an estimate from a local report and not an academic prevalence figure)
Ming Pao Health (明報健康網), quoting data from The Chinese University of Hong Kong (local report)
About 17%
Proportion of patients who develop compulsive side effects such as shopping, binge eating or gambling after taking dopamine receptor agonists, quoted by a local neurology expert
Ming Pao Health (明報健康網) (Dr 陳然欣, neurology, Faculty of Medicine, The Chinese University of Hong Kong, local report)

Why families find it hard to notice early

The greatest harm that ICD does to a family often lies not in the out-of-control behaviour itself, but in the fact that the family usually has no idea that it is a drug side effect. As a result, many families find out that the whole matter was related to the medicine only after the patient has lost lifelong savings, built up heavy credit card debt, or the family relationship has broken down.

This blind spot has two main causes. First, the family simply does not know that Parkinson's medicines can cause this kind of side effect, so it is natural to blame the out-of-control behaviour on the patient "going bad" or "going bad in old age". Second, the patient often does not realise the behaviour is a problem, or hides it out of shame (especially behaviour involving gambling and sex). With these two factors together, the problem often only comes to light when it is already extremely serious.

That the patient hides it out of shame is the main reason why this problem is hardest to find. Most of these unusual behaviours involve money, gambling and sex, and patients seldom speak up about them. If the family scolds them, they only hide it deeper. The family's attitude is therefore very important. It should not be seen as moral failure, and should be understood as a drug side effect that needs to be dealt with early.

Checklist of unusual behaviour in daily life

Families do not need a complicated professional assessment. They only need to watch for the kinds of unusual change below in daily life. If the patient shows any of the following, it is worth taking seriously and telling the treating doctor:

  • Unusual finances: large or frequent spending suddenly appearing in a bank account or on a credit card, the patient starting to borrow money or buy on credit, or money running out every month end.
  • Out-of-control shopping: a home suddenly piled with a lot of online parcels, and a lot of things bought that are not needed at all.
  • Online or gambling behaviour: staying up late at night and spending long hours online, or often opening gambling apps and betting websites.
  • Changes in sexual matters: a clear rise in sex drive, often browsing pornographic content, or a clear change in speech and behaviour.
  • A sharp rise in weight: weight increasing clearly in a short time because of out-of-control binge eating.
  • Repetitive actions: repeating the same action non-stop for a long time, for example taking apart and putting together objects again and again, or tidying things endlessly (that is punding).
  • Never question, shame or scold the patient, because this only makes the patient hide more and does not help to solve the problem.

Clinically, healthcare staff can use a screening tool (such as the QUIP questionnaire, which covers gambling, sex, shopping, eating and other compulsive behaviours) to make systematic records, but screening is not the same as a formal diagnosis, and the final decision still has to be made by the doctor (Weintraub et al., 2009). For families, the most practical step is to help record what the unusual behaviour looks like and when it happens, and hand it to the doctor at the appointment.

Three steps to take when symptoms are suspected

Once ICD is suspected in a family member with the illness, doing the three things below right often matters more than any remedy afterwards:

  1. 1
    Do not scold, and do not blame the person's character
    The family should remind themselves that this is a drug side effect and the patient's nature has not turned bad. Scolding only hurts feelings and makes the patient even less willing to speak up. The family can say calmly to the patient: "This may have something to do with your medicine, so let's tell the doctor together at the next appointment."
  2. 2
    Tell the prescribing doctor as soon as possible
    Contact the neurologist or geriatrician who originally prescribed the medicine as soon as possible, and tell the doctor truthfully what unusual behaviour the patient has shown, and when and how often. ICD is a drug problem that can be managed, and the earlier the doctor is told, the smaller the effect on the family and its finances.
  3. 3
    Do not stop the medicine or change the dose alone
    Stopping a dopamine agonist suddenly can cause a "withdrawal syndrome" and also makes motor symptoms worse (see the next section). How to reduce or switch medicines step by step must be decided by the doctor. What the family does is observe and report to the doctor, and never change medicines alone.

Directions for adjusting medicine and the medical evidence

The first-line approach to managing ICD clinically is for the doctor to assess and consider reducing the dose of, or stopping, the dopamine agonist. This direction has solid medical evidence behind it. The prospective study published by Corvol et al. in 2018 showed that, after the agonist was reduced or stopped under a doctor's guidance, ICD symptoms faded step by step within a year in about half of patients, which fully shows that the side effect is "caused by medicine and reversible with medicine".

Reducing medicine must be guided by the doctor, and stopping it alone is very dangerous. Stopping a dopamine agonist suddenly can cause "dopamine agonist withdrawal syndrome", in which the patient has anxiety, sweating, agitation, pain and a strong wish to take the medicine again. It also makes motor symptoms such as tremor, stiffness and slowness clearly worse. So even if the family badly wants to stop these behaviours as soon as possible, they must never stop or reduce the medicine alone, and it must be adjusted step by step by the prescribing doctor (Zhang et al., 2021).

As for other treatments, it has to be said frankly that the current medical evidence is not strong. For drug treatment (for example amantadine, SSRIs, antipsychotics or naltrexone), the related research evidence is insufficient (Zhang et al., 2021). The only non-drug approach currently supported by a randomised controlled trial is cognitive behavioural therapy (CBT). Note, however, that the study was only a small trial of 44 people. Although it showed that "CBT together with standard care" improved the severity of overall symptoms significantly more than "standard care alone" (p<0.001), the small sample and only moderate effect mean that more large studies are needed to verify it (Okai et al., 2013).

For this reason, our team does not claim to be able to treat ICD. The focus of our service is early recognition, helping with referral to a doctor, and supporting the family. As for surgical treatments such as deep brain stimulation (DBS), which can sometimes reduce the patient's need for medicine, whether a patient is suitable for surgery and the specific medical arrangements need a full assessment by the neurology team, and are outside the scope of this page.

Hallucinations and delusions that may appear in the middle and late stages

Besides ICD, when Parkinson's disease reaches the middle and late stages, some patients may also have hallucinations (most often visual, for example seeing people or animals that are not there) and may even develop delusions(for example suspecting persecution, or that the spouse is unfaithful). These symptoms are likewise related to the dose of dopamine medicines, the progress of the disease and decline in cognitive function, and they do not mean "madness" or a problem of character.

The principle for dealing with them is the same as for ICD: the treating doctor must be told as soon as possible. The doctor usually looks first for triggers (such as a physical infection or a recent change of medicine), then adjusts the Parkinson's medicines step by step, and prescribes a safer medicine for control when necessary. Families should not manage this alone or struggle on by themselves.

Help that the home therapy team can give

On this subject, the role of NovaHealth is to give support, and not to prescribe or adjust medicines. For anything involving an adjustment of medicine, the team always advises the family to refer back to the treating doctor. Where a therapist can help is in practical support at the household level:

Support that the home therapy team can give

  • Observing and recording the patient's behaviour changes in the actual home environment, and organising them into objective information that makes it easier for the family to talk with the doctor at the appointment.
  • Teaching the family to communicate with the patient without criticism and without hurting feelings, to ease the tension at home.
  • Helping the patient to build safe, regular daily activity habits, and dealing with the decline in fitness and risk of falls caused by binge eating or sitting still for long periods.
  • When the therapist notices that the patient has symptoms that may be ICD, reminding the family early to book a doctor's appointment.

What the therapy team will not do

  • Will not prescribe, increase, reduce or stop any medicine.
  • Will not judge alone whether the patient needs to reduce a dopamine agonist.
  • Will not take the place of the neurologist in managing psychiatric symptoms such as hallucinations and delusions.
  • Will not advise the family to solve the problem privately behind the back of the treating doctor.

Where to get medical help, and community support organisations

In the following situations, the family should not wait until the next appointment. They should contact the treating doctor or seek help elsewhere at once: the family's finances or relationships have already been seriously harmed, the patient's sexual behaviour has become very distressing to the people around or threatens safety, the patient starts to have hallucinations or delusions, or the carer is close to physical and mental collapse. In Hong Kong, families can seek help through the following routes:

  • Treating doctor / Hospital Authority outpatient clinic—The only correct route for adjusting medicines is the neurologist or geriatrician who originally prescribed them. If the patient is followed up at a public hospital, this can be done through the neurology and geriatric specialist outpatient clinics of the Hospital Authority.
  • Hong Kong Movement Disorders Society (HKMDS)—Provides patient education information on Parkinson's disease and movement disorders, to help patients and families understand the illness and how it responds to medicines (a local organisation).
  • The University of Hong Kong Jockey Club "柏動愛" Parkinson's care programme / Hong Kong Society for Rehabilitation—Provides community rehabilitation services, carer support and patient mutual-help groups (local organisations).

This page is carer education written from the occupational therapy point of view. Any medical question about adjusting medicines (for example reducing the dose of an agonist) or managing hallucinations or psychiatric symptoms must be handled by a neurologist or the treating doctor. For community subsidies and care support arrangements, phone the organisations above, or ask through the Hospital Authority and the Social Welfare Department.

Frequently asked questions

After my father started Parkinson's medicine he suddenly became addicted to gambling and shops online compulsively. Has his character turned bad?
Most likely not. This sudden addiction to gambling, loss of control over shopping, rise in sex drive or binge eating is medically called an "impulse control disorder" (ICD), and it is a known side effect of the "dopamine receptor agonists" commonly used to treat Parkinson's disease (for example pramipexole and ropinirole). These medicines over-stimulate the dopamine circuit in the brain that deals with "reward and pleasure", so the patient loses self-control over gambling, shopping, sexual behaviour and eating (Zhang et al., 2021). The Drug Office of the Department of Health in Hong Kong also lists "compulsive behaviours such as increased sex drive, gambling and binge eating" as side effects of these medicines. This is therefore a reaction of the brain caused by medicine. It is not a breakdown of character or a moral problem, and the family should not scold the person for "going bad in old age".
Is this common? Does it only happen to very few people?
It is not rare. A large study of more than three thousand patients (DOMINION) found that about 13.6% of people with Parkinson's disease overall had an impulse control disorder. Among patients taking a dopamine agonist the rate was as high as 17.1%, more than twice that of those not taking it (6.9%) (Weintraub et al., 2010). A five-year follow-up study in France also pointed out that the cumulative incidence over five years in early-stage patients was as high as about 46%, and the higher the dose and the longer the treatment, the greater the risk (Corvol et al., 2018). Experts at The Chinese University of Hong Kong have also quoted that about 17% of patients taking such medicines develop related compulsive behaviours. In other words, if the patient is taking a dopamine agonist and shows unusual behaviour, the family must consider this possibility.
Is it enough to stop the medicine straight away?
Do not stop the medicine or change the dose alone. Stopping a dopamine agonist suddenly can cause a "withdrawal syndrome" (anxiety, sweating, agitation, pain and a strong craving to take the medicine again), and also makes motor symptoms such as tremor, stiffness and slowness clearly worse (Zhang et al., 2021). The right approach is to contact as soon as possible the neurologist or geriatrician who prescribed the medicine, and the doctor decides how to reduce it step by step, switch to another medicine or adjust the dose of levodopa. Encouragingly, research shows that after the agonist is reduced or stopped under a doctor's guidance, the impulsive behaviour fades within a year in about half of patients (Corvol et al., 2018). This proves that the condition is "caused by medicine and reversible with medicine", but it must be handled by the doctor.
As a family member, how can I notice it early in daily life?
Families can watch for the following everyday warning signs: large or frequent spending suddenly appearing in a bank account or on a credit card, borrowing or buying on credit, a home suddenly piled with online parcels, staying up late at night and spending long hours online or using gambling apps, a clear change in browsing history or talk about sex, a sudden big weight gain in a short time (binge eating), or repeating the same action for a long time (for example taking apart and putting together objects or tidying them non-stop, which is called punding in medicine) (Weintraub et al., 2009). When these are seen, do not question or scold, because the patient often does not realise there is a problem, or hides it out of shame. The family can say calmly: "This may have something to do with your medicine, so let's tell the doctor together at the next appointment." The family can also help by recording when the unusual behaviour happens and what it looks like, for the doctor to refer to at the appointment.
I have heard that hallucinations appear in the later stage. Are they also caused by medicine?
When Parkinson's disease reaches the middle and late stages, some patients may have hallucinations (most often visual, for example seeing people or animals that are not there), and may even develop delusions (for example suspecting persecution or that the spouse is unfaithful). These symptoms are likewise related to the dose of dopamine medicines, the progress of the disease and cognitive decline, and they do not mean "madness" or a flaw of character. The way to deal with them is also to tell the treating doctor as soon as possible, so that the doctor can assess whether the current medicines need adjusting, or whether a safer medicine should be prescribed when necessary. Families should not try to manage this alone or struggle on by themselves.
What help can the NovaHealth home therapy team offer on this?
Our team's role is to give support, and not to prescribe or adjust medicines. For anything involving a change of medicine, we always advise the family to refer back to the treating doctor. A visiting therapist can observe and record the patient's behaviour changes in the home (for the family to use when talking with the doctor), guide the family to communicate with the patient without judgement and without hurting feelings, help to build safe daily activity habits, and deal with the decline in fitness and risk of falls that follow from binge eating, long periods of sitting or limited mobility. If the therapist notices that the patient may have an impulse control problem, the therapist reminds the family to see the doctor promptly, and will never interfere with medication alone.

Disclaimer: This article is general health information and is not professional medical advice. If you have any health concerns, please consult a qualified healthcare professional.

References

  1. Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., Whetteckey, J., Wunderlich, G. R., & Lang, A. E. (2010). Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients (DOMINION study). Archives of Neurology, 67(5), 589–595. https://pubmed.ncbi.nlm.nih.gov/20457959/
  2. Corvol, J. C., Artaud, F., Cormier-Dequaire, F., Rascol, O., Durif, F., Derkinderen, P., … Elbaz, A.; DIGPD Study Group. (2018). Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology, 91(3), e189–e201. PMC6059034
  3. Zhang, J. F., Wang, X. X., Feng, Y., Fekete, R., Jankovic, J., & Wu, Y. C. (2021). Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies. Frontiers in Psychiatry, 12, 635494. PMC7900512
  4. Voon, V., Napier, T. C., Frank, M. J., Sgambato-Faure, V., Grace, A. A., Rodriguez-Oroz, M., Obeso, J., Bezard, E., & Fernagut, P. O. (2017). Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update. The Lancet Neurology, 16(3), 238–250. https://pubmed.ncbi.nlm.nih.gov/28229895/
  5. Okai, D., Askey-Jones, S., Samuel, M., O'Sullivan, S. S., Chaudhuri, K. R., Martin, A., Mack, J., Brown, R. G., & David, A. S. (2013). Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology, 80(9), 792–799. https://pubmed.ncbi.nlm.nih.gov/23325911/
  6. Weintraub, D., Stewart, S., Shea, J. A., et al. (2009). Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP). Movement Disorders, 24(10), 1461–1467. PMC2848971
  7. Drug Office, Department of Health, Hong Kong (香港衞生署藥物辦公室). Oral anti-Parkinson's medicines (consumer drug information). Lists compulsive behaviours (increased sex drive, gambling, binge eating) as side effects of dopamine agonists. drugoffice.gov.hk (local official source)
  8. 明報健康網 (Ming Pao Health), quoting Dr 陳然欣, Honorary Clinical Associate Professor, Division of Neurology, Faculty of Medicine, The Chinese University of Hong Kong. Report on dopamine agonists and impulse control behaviours in Parkinson's disease (excessive shopping, binge eating, gambling, about 17%; about 12,000 patients estimated in Hong Kong). health.mingpao.com (estimate from a local report)